ASN shapes federal policies, increases federal and institutional resources, and influences regulatory directives to help its members. https://www.asn-online.org/policy/ en-us Copyright 2026 Sun, 28 Jun 2026 07:11:35 GMT Sun, 28 Jun 2026 07:11:35 GMT http://blogs.law.harvard.edu/tech/rss hnesbitt@asn-online.org (Hal Nesbitt) https://www.asn-online.org/images/_global/apple-touch-icon.png https://www.asn-online.org/policy/ https://www.asn-online.org/policy/webdocs/research_societies_request_congressional_support.pdf frontID=310 ASN urged Congress not to support proposed restrictions on using research grants to cover publication costs, arguing that peer-reviewed publication is an essential part of the research process. Tue, 23 Jun 2026 18:58:11 GMT https://www.asn-online.org/policy/webdocs/Request_for_OMB_comment_period_extension.pdf frontID=309 In a letter to OMB Director Vought, ASN requested that the Regulation for Federal Financial Assistance comment period be extended 45 days due to the vast scope and impact it poses. Tue, 23 Jun 2026 18:51:53 GMT https://www.asn-online.org/policy/webdocs/Battelle_Quality_Measurement_EM_Comments.pdf frontID=308 ASN submitted comments in response to Battelle's Partnership for Quality Measurement (PQM) Spring 2026 Endorsement and Maintenance (E&M) comment period. In the letter, ASN strongly supported endorsement of the Rate of Annual Kidney Health Evaluation Among Adults with Diabetes and/or Hypertension measure (CBE 5611e), emphasizing that endorsement of the measure would promote greater accountability and consistency in kidney health screening across the healthcare system. ASN also supported the inclusion of Medicare Advantage beneficiaries in four dialysis facility-level quality measures, noting that incorporating MA patients is essential to ensuring that quality measurement fully and accurately reflects the entire ESRD population, including the growing number of patients enrolled in MA plans. Tue, 23 Jun 2026 18:39:47 GMT https://www.asn-online.org/policy/webdocs/NIH_Multisociety_sign_on_letter_6.16.26.pdf frontID=307 ASN urges Congressional leaders to provide $51.3 billion for the NIH in FY2027 and ensure those funds are spent in accordance with congressional intent. Tue, 16 Jun 2026 17:03:45 GMT https://www.asn-online.org/policy/webdocs/AMA_Provider_Stability_Act_2026.pdf frontID=306 ASN urged Congress to pass the Provider Reimbursement Stability Act and modernize Medicare physician payment policies, improve reimbursement stability and accuracy, and help preserve patient access to care. Tue, 09 Jun 2026 15:00:29 GMT https://www.asn-online.org/policy/webdocs/FY27_LHHS_ED_Coalition.pdf frontID=305 ASN urges Congress to reject proposed FY27 cuts and instead strengthen Labor-HHS-Education funding to protect and expand essential programs in health, education, workforce development, and social services. Tue, 09 Jun 2026 14:23:28 GMT https://www.asn-online.org/policy/webdocs/CHF_Thank_You_FY26_Funding.pdf frontID=304 ASN joined the Coalition for Health Funding in partnering with more than 50 organizations to thank Congress for the FY26 appropriation package and offer to serve as a resource during the FY27 process. Wed, 03 Jun 2026 20:55:24 GMT https://www.asn-online.org/policy/webdocs/26.04.16ASNKCCLetterFINAL.pdf frontID=302 In the letter, ASN offers recommendations to strengthen and improve future iterations of the Kidney Care Choices (KCC) Model. Mon, 20 Apr 2026 18:33:20 GMT https://www.asn-online.org/policy/webdocs/NIH_FY_2027_Budget_Statement_for_Research.pdf frontID=301 ASN joins more than 90 research and patient advocacy organizations to urge Congress to reject the administration's proposed 12% cut to NIH funding, oppose structural changes, and instead provide $51.3 billion in FY27 to sustain biomedical research and innovation. Wed, 15 Apr 2026 16:37:44 GMT https://www.asn-online.org/policy/webdocs/Sickle_Cell_Disease_Comprehensive_Care_Act_2026.pdf frontID=300 ASN urges Congress to pass the Sickle Cell Disease Comprehensive Care Act to improve access to Medicaid-supported care for individuals with sickle cell disease, addressing gaps in quality, and health outcomes. Tue, 14 Apr 2026 22:50:06 GMT